SlideShare a Scribd company logo
Para-sympathomimetics
(Cholinergics)
Aasifa shaikh
Sem I
Department of Pharmacology
SSR COLLEGE OF PHARMACY
•These are the drugs that produce
actions similar to that of Ach
either by directly interacting with
cholinergic receptors (cholinergic
agonists) or by increasing
availability of ACh at these sites
(anticholinesterases).
Parasymapathomimetic
Directly acting Indirectly acting
Directly acting
Choline esters
Eg-
acetylcholine
carbachol
Natural
alkaloids
Eg- muscarine
pilocarpine
Synthetic
alkaloids
Eg-areclidine
oxotremorine
Mechanism of directly acting
•The drug directly bind to the
receptor and prevents the binding
of agonist to the recptor.
Indirectly acting
(Anticholine
esterase)
Natural
Eg- physostigmine
Synthetic
Synthetic
Reversible
Eg- Neostigmine
Pyridostigmine
Irreversible
Eg- Sarin
Parathion, methation
Mechanism of indirectly acting
•This is non receptor blocker
•Drug do not bind to the receptor
site but they indirectly inhibit the
activity of Ach esterase and thus
preserve Ach at nerve endings.
• There are 2 types of choline
esterase enzyme:
True choline esterase
Pseudo choline esterase
True choline esterase(specific)
•Found in nervous tissue, human
placenta, erythrocytes.
•Hydrolyse Ach liberated at nerve
endings.(mainly endogeneously released
Ach)
•Have high affinity for Ach.
Pseudo choline esterase(non-specific)
•Found in blood serum, intestine, skin
•Have low affinity for Ach
Mechanism of anti-choline esterase
•The anti-ChEs react with the
enzyme essentially in the same way
as ACh. The carbamates and
phosphates respectively are
carbamylate and phosphorylate the
esteratic site of the enzyme
•The active region of AChE forms a
gorge which contains an anionic site
ie. glutamatic acid and an esteratic
site formed by serine and histidine.
Hydrolysis of ACh involves electrostatic
attraction of positively charged N+ of ACh to
the anionic site and nucleophilic attack by
serine-OH which is activated by the adjacent
histidine leading to acetylation of serine
• The acetylated enzyme reacts with water
to produce acetic acid and choline.
•Whereas the acetylated enzyme reacts
with water extremely rapidly and the
esteratic site is freed in a fraction of a
millisecond
•The intermediate formed is
carbamylated enzyme.
•Its half life is 30min (slow reaction)
•Irreversible AntiCEs act on the
enzyme CE in a similar fashion.
•Organophosphorus compound bind
to the esteric site only and the
intermediate formed is
phosphorylated enzyme which is
stable.
• The phosphorylated enzyme may
also undergo ‘aging’ by the loss of
one of the alkyl groups and
become totally resistant to
hydrolysis
•The enzyme is never regenerated &
return of the activity depends on the
synthesis of new enzyme hence, these
are irreversible blocking agents.
•These compounds are useful in
reversing neuro muscular paralysis due
to organophosphorus compound
where atropine is ineffective or
contraindicated.
•Organophosphorus compound
poisoning may occur due to accidental
consumption of agricultural product
spread with insecticides/ pesticides, or
if the person is occupationally involved
in spraying insecticides.
•Poisoning may occur in suicidal cases.
Pharmacological actions: (directly)
Muscarinic agonists
1- Heart
M2receptor
s present in
atria &
ventricles
which are
negatively
coupled
with
adenylate
cyclase
Reduce
cAMP
formation
so Decrease
Ca+2 release
Open K+
channel
Increase
permeabilit
y of K+ ion
Produce
hyperpolari
zation
Decrease
heart
rate
Blood vessel
M3 receptor is
present in
blood vessel
endothelium
Causes
activation of
protein kinase
C and releases
Ca+2 which
combine with
calmoduline
and form its
complex
Activation
of NO
synthase
(increase
NO)
Vasodialati
on
(decrease
B.P)
• When the endothelium is
damaged by disease, ACh can
diffuse to the vascular smooth
muscle and cause vasoconstriction
via M3 receptors located on their
plasma membrane.
M3 receptor causes activation of PKC
Release of Ca+2
Contract smooth muscle
2- Smooth muscle
Respiratory system
These types of drugs are
contraindicated in Asthma as the
bronchial muscles are contracted
to produce bronchospasm.
Urinary bladder
•Contraction of the middle layer
termed as DETRUSOR muscle
& relaxation of the sphincter
muscle , hence produce
micturition.
•Bethanechol is used to
stimulate bladder emptying.
Effects on eye
•Cholinergic drugs produces
miosis of eye causing
contraction of circular muscle.
•Contraction of ciliary muscle
leads to spasm increased
outflow facility reduction in
intraocular tension (especially in
glaucomatous patients).
Drugs used to lower intraocular
pressure
•Timolol (eye drop) acts as β-
adrenoceptor antagonist is used
•Clonidine as α2-adrenoceptor
agonist
•Pilocarpine as muscarinic agonist
•In addition to these peripheral
effects, muscarinic agonists that
are able to penetrate the blood–
brain barrier produce marked
central effects due to
activation mainly of M1
receptors in the brain.
•These include tremor,
hypothermia and increased
locomotor activity, as well
as improved cognition as in
Mysthenia Gravis.
Nicotinic agonists
1. Autonomic ganglia
Both sympathetic and parasympathetic ganglia are stimulated.
High dose of ACh given after atropine causes tachycardia
rise in BP due to stimulation of sympathetic ganglia and release
of catecholamines
2. Skeletal muscles
•Causes contraction through nicotinc effect
3. CNS
•Ach when injected through IV donot
cross BBB , but when given directly in
brain it produces aurosal response
followed by depression
Acetyl choline ester
•It is rapidly hydrolysed , so ineffective
orally. (therapeutically ineffective)
•Carbachol and bethanichol are absorbed
orally & are relatively resistant to
choline ester.
Pharmacological actions of indirectly
acting drugs
1-Autonomic cholinergic synapses- These mainly
reflect enhancement of Ach activity at
parasympathetic postganglionic synapses.
Large doses will first stimulate & later block the
autonomic ganglia producing complex autonomic
effect.
The depolarization block occurs and is associated
with a build-up of Ach in the plasma and body
fluids.
2-Effect on neuromuscular junction-
The twitch tension of a muscle stimulated
via its motor nerve is increased by
anticholinesterases.
Normally, the Ach is hydrolysed so quickly
that each stimulus initiates only one action
potential in the muscle fibre, but when
AChE is inhibited this is converted to a short
train of action potentials in the muscle fibre,
and hence greater tension.
3- Effect on CNS
•Tertiary compounds, such as physostigmine,
and the non-polar organophosphates penetrate
the blood–brain barrier freely and affect the
brain. The result is an initial excitation, which
can result in convulsions, followed by
depression, which can cause unconsciousness
and respiratory failure. These central effects
result mainly from the activation of mAChRs,
and are antagonized by atropine.
4- CVS
• Cardiovascular effects are complex.
•Whereas muscarinic action would produce bradycardia
and hypotension.
• Ganglionic stimulation would tend to increase heart rate
and BP.
•Action on medullary centres (stimulation followed by
depression) further complicates the picture, so does
ganglionic blockade with high doses.
•Thus, the overall effects are often unpredictable and
depend on the agent and its dose.
5-Neurotoxicity of organophosphates
•Many organophosphates can cause a severe type of
delayed peripheral nerve degeneration, leading to
progressive weakness and sensory loss.
•This is not a problem with clinically used
anticholinesterases but occasionally results from
poisoning with insecticides or nerve gases.
• The mechanism of this reaction is only partly
understood, but it seems to result from inhibition
of a neuropathy target esterase distinct from
cholinesterase.
Physostigmine
•It is an alkaloid obtained from dried
ripe seeds of Physostigma venenosum.
•A tertiary ammonium compound
•Well absorbed from GIT and can cross
BBB.
•Equally active against both true and
pseudo CE.
Therapeutic uses of physostigmine
1. Pilocarpine- to treat glaucoma.
2. Atropine poisoining
3. Early stages of Alzhemier’s disease and
improve memory.
Therapeutic uses
1. Glaucoma- by contracting ciliary and circular
muscle
Drug useful is physostigmine in doses of 0.1- 1% aq
solution or
Pilocarpine 0.5- 4% Aq sol.
2. Mysthenia gravis –
• by contraction of muscle
• Drug used is neostigmine
• As it cannot cross BBB and it directly produces
cholinomimetic action
• It has selective action on skeletal muscle
3. Atropine poisoining-
physostigmine is commonly used as it can cross BBB
4. Curare poisoining- neostigmine is used
5. Misce. Use –
Physostigmine is used in Alzhemiers disease by decreasing
the metabolism of Ach
•Methacholine & neostigmine are sometimes used in
tachycardia
• Attony of bladder and paralytic ileus– if the spasm of
bladder is not proper than Methacholine carbachol is
prescribed
ANTICHOLINESTERASE POISONING
•Anticholinesterases are easily available and
extensively used as agricultural and household
insecticides; accidental as well as suicidal and
homicidal poisoning is common.
•Local muscarinic manifestations at the site of
exposure (skin, eye, g.i.t.) occur immediately
and are followed by complex systemic effects
due to muscarinic, nicotinic and central actions.
They are—
• Irritation of eye, lacrimation, salivation,
sweating, copious tracheo-bronchial secretions,
miosis, blurring of vision, bronchospasm,
breathlessness, colic, involuntary defecation and
urination.
•Fall in BP, bradycardia or tachycardia, cardiac
arrhythmias, vascular collapse.
• Muscular fasciculations, weakness, respiratory
paralysis (central as well as peripheral).
• Irritability, disorientation, unsteadiness,
tremor, ataxia, convulsions, coma and death.
• Death is generally due to respiratory failure
Treatment
1. Termination of further exposure to the poison—
fresh air, wash the skin and mucous membranes with
soap and water, gastric lavage according to need.
2. Maintain patent airway, positive pressure
respiration if it is failing.
3. Supportive measures—maintain BP, hydration,
control of convulsions with judicious use of
diazepam.
4. Specific antidotes—
(a) Atropine :
•It is highly effective in counteracting the muscarinic
symptoms, but higher doses are required to antagonize
the central effects.
•It does not reverse peripheral muscular paralysis which is
a nicotinic action.
•All cases of anti-ChE (carbamate or organophosphate)
poisoning must be promptly given atropine 2 mg i.v.
repeated every 10 min till dryness of mouth or other signs
of atropinization appear (upto 200 mg has been
administered in a day). Continued treatment with
maintenance doses may be required for 1–2 weeks.
(b) Cholinesterase reactivators
•Oximes are used to restore neuromuscular transmission
only in case of organophosphate anti-ChE poisoning.
•The phosphorylated ChE reacts very slowly or not at all
with water.
•However, if more reactive OH groups in the form of
oximes (generic formula R–CH = N–OH) are provided,
reactivation occurs more than a million times faster.
•Pralidoxime (2-PAM) has a positively
charged quaternary nitrogen: attaches to
the anionic site of the enzyme which
remains unoccupied in the presence of
organophosphate inhibitors.
•Its oxime end reacts with the phosphorus
atom attached to the esteratic site: the
oxime-phosphonate so formed diffuses
away leaving the reactivated ChE.
• Pralidoxime is ineffective as an antidote to
carbamate anti-ChEs (physostigmine,
neostigmine, carbaryl, propoxur) in which case
the anionic site of the enzyme is not free to
provide attachment to it.
•It is rather contraindicated in carbamate
poisoning, because not only it does not
reactivate carbamylated enzyme, it has weak
anti-ChE activity of its own.
Chronic organophosphate poisoning
• Repeated exposure to certain fluorine
containing and triaryl organophosphates
results in polyneuritis and demyelination after
a latent period of days to weeks.
•Sensory disturbances occur first followed by
muscle weakness, tenderness and depressed
tendon reflexes—lower motor neurone
paralysis.
•In the second phase, spasticity and upper
motor neurone paralysis gradually
supervenes.
•Recovery may take years.
• The mechanism of this toxicity is not known,
but it is not due to inhibition of ChE; there is
no specific treatment.
Adverse effects of
parasympathomimetics
• Excessive salivation
• Asthma
• Peptic ulcer
• Coronary insuffiency
• Hyperthyrodism
• Apnoea
• Nausea vomiting
• Contraindication

More Related Content

What's hot

Parasympathomimetic drugs
Parasympathomimetic drugsParasympathomimetic drugs
Parasympathomimetic drugs
Anurag Chourasia
 
Seminar on parasympathomimetic and parasympatholytic converted
Seminar on parasympathomimetic and parasympatholytic convertedSeminar on parasympathomimetic and parasympatholytic converted
Seminar on parasympathomimetic and parasympatholytic converted
B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote
 
Sympatholytics.pptx
Sympatholytics.pptxSympatholytics.pptx
Sympatholytics.pptx
A M O L D E O R E
 
NEUROHUMORAL TRANSMISSION
NEUROHUMORAL TRANSMISSIONNEUROHUMORAL TRANSMISSION
NEUROHUMORAL TRANSMISSION
Heena Parveen
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
Dr Roohana Hasan
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
Shagufta Farooqui
 
Anticholinergics and drugs acting on autonomic ganglia- drdhriti
Anticholinergics and drugs acting on autonomic ganglia- drdhritiAnticholinergics and drugs acting on autonomic ganglia- drdhriti
Anticholinergics and drugs acting on autonomic ganglia- drdhriti
http://neigrihms.gov.in/
 
UNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonistUNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonist
SONALI PAWAR
 
Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology.
Javeria Fateh
 
Drugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucomaDrugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucoma
AshviniGovande
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
Kameshwaran Sugavanam
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
AnkurJoshi62
 
Sedatives and hypnotics
Sedatives and hypnotics Sedatives and hypnotics
Sedatives and hypnotics
Madan Sigdel
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopamine
sumitwankh
 
Antiepileptic drugs
Antiepileptic drugs Antiepileptic drugs
Antiepileptic drugs
Karun Kumar
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
Dr Resu Neha Reddy
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
Kirti Vadi
 
Cholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugsCholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugs
Sri Ramachandra Medical college and Research Institute
 
CNS stimulants and cognitive enchancers
CNS stimulants and cognitive enchancersCNS stimulants and cognitive enchancers
CNS stimulants and cognitive enchancers
Koppala RVS Chaitanya
 
Pharmacology of the Autonomic nervous system
Pharmacology of the Autonomic nervous systemPharmacology of the Autonomic nervous system
Pharmacology of the Autonomic nervous system
Mohaned Massaad
 

What's hot (20)

Parasympathomimetic drugs
Parasympathomimetic drugsParasympathomimetic drugs
Parasympathomimetic drugs
 
Seminar on parasympathomimetic and parasympatholytic converted
Seminar on parasympathomimetic and parasympatholytic convertedSeminar on parasympathomimetic and parasympatholytic converted
Seminar on parasympathomimetic and parasympatholytic converted
 
Sympatholytics.pptx
Sympatholytics.pptxSympatholytics.pptx
Sympatholytics.pptx
 
NEUROHUMORAL TRANSMISSION
NEUROHUMORAL TRANSMISSIONNEUROHUMORAL TRANSMISSION
NEUROHUMORAL TRANSMISSION
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
 
Anticholinergics and drugs acting on autonomic ganglia- drdhriti
Anticholinergics and drugs acting on autonomic ganglia- drdhritiAnticholinergics and drugs acting on autonomic ganglia- drdhriti
Anticholinergics and drugs acting on autonomic ganglia- drdhriti
 
UNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonistUNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonist
 
Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology.
 
Drugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucomaDrugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucoma
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
 
Sedatives and hypnotics
Sedatives and hypnotics Sedatives and hypnotics
Sedatives and hypnotics
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopamine
 
Antiepileptic drugs
Antiepileptic drugs Antiepileptic drugs
Antiepileptic drugs
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
 
Cholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugsCholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugs
 
CNS stimulants and cognitive enchancers
CNS stimulants and cognitive enchancersCNS stimulants and cognitive enchancers
CNS stimulants and cognitive enchancers
 
Pharmacology of the Autonomic nervous system
Pharmacology of the Autonomic nervous systemPharmacology of the Autonomic nervous system
Pharmacology of the Autonomic nervous system
 

Similar to Para sympathomimetics

Cholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGY
Cholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGYCholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGY
Cholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGY
Shweta Gupta
 
ANS.pdf
ANS.pdfANS.pdf
ANS.pdf
KoangWichyoah
 
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Mirza Anwar Baig
 
CHOLINERGIC NEUROTRANSMITTERS.pptx
CHOLINERGIC NEUROTRANSMITTERS.pptxCHOLINERGIC NEUROTRANSMITTERS.pptx
CHOLINERGIC NEUROTRANSMITTERS.pptx
Saithanpari
 
Anticholinestrases
AnticholinestrasesAnticholinestrases
Anticholinestrases
Dr. Pramod B
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
SabaShaikh76
 
Week 10 lec 2 hCholinergic agonists.pptx
Week 10 lec 2 hCholinergic agonists.pptxWeek 10 lec 2 hCholinergic agonists.pptx
Week 10 lec 2 hCholinergic agonists.pptx
DRAAM1
 
Anticholinergic agents in psychiatry
Anticholinergic agents in psychiatryAnticholinergic agents in psychiatry
Anticholinergic agents in psychiatry
Jithin Mampatta
 
2 Pharmacology I, intro ANS cholinergic drugs.pptx
2 Pharmacology I,  intro ANS  cholinergic drugs.pptx2 Pharmacology I,  intro ANS  cholinergic drugs.pptx
2 Pharmacology I, intro ANS cholinergic drugs.pptx
Ahmad Kharousheh
 
Miotics mydriatics cycloplegics
Miotics mydriatics cycloplegicsMiotics mydriatics cycloplegics
Miotics mydriatics cycloplegics
Chakri Psb
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
Kalaivanisathishr
 
cholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptxcholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptx
ABHIJIT BHOYAR
 
L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018
College of Pharmacy University of Sulaimani
 
Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptx
Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptxCholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptx
Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptx
RashmiChauhan61
 
AUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptxAUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptx
HamseHaybe
 
Myesthenia gravis.pptx
Myesthenia gravis.pptxMyesthenia gravis.pptx
Myesthenia gravis.pptx
Sana67616
 
Ans pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddhaAns pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddha
dr anurag giri
 
Ans pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddhaAns pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddha
dr anurag giri
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
shayanfatima
 
Drugs modulating cholinesterase enzyme
Drugs modulating cholinesterase enzymeDrugs modulating cholinesterase enzyme
Drugs modulating cholinesterase enzyme
Dr. Pooja
 

Similar to Para sympathomimetics (20)

Cholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGY
Cholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGYCholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGY
Cholinergic MK GUPTA, ANS, PARASYMPATHATIC PHARMACOLOGY
 
ANS.pdf
ANS.pdfANS.pdf
ANS.pdf
 
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
 
CHOLINERGIC NEUROTRANSMITTERS.pptx
CHOLINERGIC NEUROTRANSMITTERS.pptxCHOLINERGIC NEUROTRANSMITTERS.pptx
CHOLINERGIC NEUROTRANSMITTERS.pptx
 
Anticholinestrases
AnticholinestrasesAnticholinestrases
Anticholinestrases
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
Week 10 lec 2 hCholinergic agonists.pptx
Week 10 lec 2 hCholinergic agonists.pptxWeek 10 lec 2 hCholinergic agonists.pptx
Week 10 lec 2 hCholinergic agonists.pptx
 
Anticholinergic agents in psychiatry
Anticholinergic agents in psychiatryAnticholinergic agents in psychiatry
Anticholinergic agents in psychiatry
 
2 Pharmacology I, intro ANS cholinergic drugs.pptx
2 Pharmacology I,  intro ANS  cholinergic drugs.pptx2 Pharmacology I,  intro ANS  cholinergic drugs.pptx
2 Pharmacology I, intro ANS cholinergic drugs.pptx
 
Miotics mydriatics cycloplegics
Miotics mydriatics cycloplegicsMiotics mydriatics cycloplegics
Miotics mydriatics cycloplegics
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
 
cholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptxcholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptx
 
L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018
 
Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptx
Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptxCholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptx
Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs.pptx
 
AUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptxAUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptx
 
Myesthenia gravis.pptx
Myesthenia gravis.pptxMyesthenia gravis.pptx
Myesthenia gravis.pptx
 
Ans pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddhaAns pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddha
 
Ans pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddhaAns pharmac,shrikant,shraddha
Ans pharmac,shrikant,shraddha
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
Drugs modulating cholinesterase enzyme
Drugs modulating cholinesterase enzymeDrugs modulating cholinesterase enzyme
Drugs modulating cholinesterase enzyme
 

More from SSR COLLEGE OF PHARMACY

Ppt toxicity evalution
Ppt toxicity evalutionPpt toxicity evalution
Ppt toxicity evalution
SSR COLLEGE OF PHARMACY
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
SSR COLLEGE OF PHARMACY
 
Sub acute
Sub acuteSub acute
Difference between toxicity studies
Difference between toxicity studiesDifference between toxicity studies
Difference between toxicity studies
SSR COLLEGE OF PHARMACY
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
SSR COLLEGE OF PHARMACY
 
Anti tuberculin drugs [autosaved]
Anti tuberculin drugs [autosaved]Anti tuberculin drugs [autosaved]
Anti tuberculin drugs [autosaved]
SSR COLLEGE OF PHARMACY
 
Methods for screening of hypoglycemics
Methods for screening of hypoglycemicsMethods for screening of hypoglycemics
Methods for screening of hypoglycemics
SSR COLLEGE OF PHARMACY
 
Route of administration
Route of administrationRoute of administration
Route of administration
SSR COLLEGE OF PHARMACY
 

More from SSR COLLEGE OF PHARMACY (8)

Ppt toxicity evalution
Ppt toxicity evalutionPpt toxicity evalution
Ppt toxicity evalution
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Sub acute
Sub acuteSub acute
Sub acute
 
Difference between toxicity studies
Difference between toxicity studiesDifference between toxicity studies
Difference between toxicity studies
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Anti tuberculin drugs [autosaved]
Anti tuberculin drugs [autosaved]Anti tuberculin drugs [autosaved]
Anti tuberculin drugs [autosaved]
 
Methods for screening of hypoglycemics
Methods for screening of hypoglycemicsMethods for screening of hypoglycemics
Methods for screening of hypoglycemics
 
Route of administration
Route of administrationRoute of administration
Route of administration
 

Recently uploaded

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
debosmitaasanyal1
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 

Recently uploaded (20)

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 

Para sympathomimetics

  • 2. •These are the drugs that produce actions similar to that of Ach either by directly interacting with cholinergic receptors (cholinergic agonists) or by increasing availability of ACh at these sites (anticholinesterases).
  • 4. Directly acting Choline esters Eg- acetylcholine carbachol Natural alkaloids Eg- muscarine pilocarpine Synthetic alkaloids Eg-areclidine oxotremorine
  • 5. Mechanism of directly acting •The drug directly bind to the receptor and prevents the binding of agonist to the recptor.
  • 8. Mechanism of indirectly acting •This is non receptor blocker •Drug do not bind to the receptor site but they indirectly inhibit the activity of Ach esterase and thus preserve Ach at nerve endings.
  • 9. • There are 2 types of choline esterase enzyme: True choline esterase Pseudo choline esterase
  • 10. True choline esterase(specific) •Found in nervous tissue, human placenta, erythrocytes. •Hydrolyse Ach liberated at nerve endings.(mainly endogeneously released Ach) •Have high affinity for Ach.
  • 11. Pseudo choline esterase(non-specific) •Found in blood serum, intestine, skin •Have low affinity for Ach
  • 12. Mechanism of anti-choline esterase •The anti-ChEs react with the enzyme essentially in the same way as ACh. The carbamates and phosphates respectively are carbamylate and phosphorylate the esteratic site of the enzyme
  • 13. •The active region of AChE forms a gorge which contains an anionic site ie. glutamatic acid and an esteratic site formed by serine and histidine.
  • 14. Hydrolysis of ACh involves electrostatic attraction of positively charged N+ of ACh to the anionic site and nucleophilic attack by serine-OH which is activated by the adjacent histidine leading to acetylation of serine
  • 15. • The acetylated enzyme reacts with water to produce acetic acid and choline. •Whereas the acetylated enzyme reacts with water extremely rapidly and the esteratic site is freed in a fraction of a millisecond
  • 16. •The intermediate formed is carbamylated enzyme. •Its half life is 30min (slow reaction)
  • 17. •Irreversible AntiCEs act on the enzyme CE in a similar fashion. •Organophosphorus compound bind to the esteric site only and the intermediate formed is phosphorylated enzyme which is stable.
  • 18. • The phosphorylated enzyme may also undergo ‘aging’ by the loss of one of the alkyl groups and become totally resistant to hydrolysis
  • 19. •The enzyme is never regenerated & return of the activity depends on the synthesis of new enzyme hence, these are irreversible blocking agents.
  • 20. •These compounds are useful in reversing neuro muscular paralysis due to organophosphorus compound where atropine is ineffective or contraindicated.
  • 21. •Organophosphorus compound poisoning may occur due to accidental consumption of agricultural product spread with insecticides/ pesticides, or if the person is occupationally involved in spraying insecticides. •Poisoning may occur in suicidal cases.
  • 22. Pharmacological actions: (directly) Muscarinic agonists 1- Heart M2receptor s present in atria & ventricles which are negatively coupled with adenylate cyclase Reduce cAMP formation so Decrease Ca+2 release Open K+ channel Increase permeabilit y of K+ ion Produce hyperpolari zation Decrease heart rate
  • 23. Blood vessel M3 receptor is present in blood vessel endothelium Causes activation of protein kinase C and releases Ca+2 which combine with calmoduline and form its complex Activation of NO synthase (increase NO) Vasodialati on (decrease B.P)
  • 24. • When the endothelium is damaged by disease, ACh can diffuse to the vascular smooth muscle and cause vasoconstriction via M3 receptors located on their plasma membrane.
  • 25. M3 receptor causes activation of PKC Release of Ca+2 Contract smooth muscle 2- Smooth muscle
  • 26. Respiratory system These types of drugs are contraindicated in Asthma as the bronchial muscles are contracted to produce bronchospasm.
  • 27. Urinary bladder •Contraction of the middle layer termed as DETRUSOR muscle & relaxation of the sphincter muscle , hence produce micturition.
  • 28. •Bethanechol is used to stimulate bladder emptying.
  • 29. Effects on eye •Cholinergic drugs produces miosis of eye causing contraction of circular muscle.
  • 30. •Contraction of ciliary muscle leads to spasm increased outflow facility reduction in intraocular tension (especially in glaucomatous patients).
  • 31. Drugs used to lower intraocular pressure •Timolol (eye drop) acts as β- adrenoceptor antagonist is used •Clonidine as α2-adrenoceptor agonist •Pilocarpine as muscarinic agonist
  • 32. •In addition to these peripheral effects, muscarinic agonists that are able to penetrate the blood– brain barrier produce marked central effects due to activation mainly of M1 receptors in the brain.
  • 33. •These include tremor, hypothermia and increased locomotor activity, as well as improved cognition as in Mysthenia Gravis.
  • 34. Nicotinic agonists 1. Autonomic ganglia Both sympathetic and parasympathetic ganglia are stimulated. High dose of ACh given after atropine causes tachycardia rise in BP due to stimulation of sympathetic ganglia and release of catecholamines
  • 35. 2. Skeletal muscles •Causes contraction through nicotinc effect 3. CNS •Ach when injected through IV donot cross BBB , but when given directly in brain it produces aurosal response followed by depression
  • 36. Acetyl choline ester •It is rapidly hydrolysed , so ineffective orally. (therapeutically ineffective) •Carbachol and bethanichol are absorbed orally & are relatively resistant to choline ester.
  • 37. Pharmacological actions of indirectly acting drugs 1-Autonomic cholinergic synapses- These mainly reflect enhancement of Ach activity at parasympathetic postganglionic synapses. Large doses will first stimulate & later block the autonomic ganglia producing complex autonomic effect. The depolarization block occurs and is associated with a build-up of Ach in the plasma and body fluids.
  • 38. 2-Effect on neuromuscular junction- The twitch tension of a muscle stimulated via its motor nerve is increased by anticholinesterases. Normally, the Ach is hydrolysed so quickly that each stimulus initiates only one action potential in the muscle fibre, but when AChE is inhibited this is converted to a short train of action potentials in the muscle fibre, and hence greater tension.
  • 39. 3- Effect on CNS •Tertiary compounds, such as physostigmine, and the non-polar organophosphates penetrate the blood–brain barrier freely and affect the brain. The result is an initial excitation, which can result in convulsions, followed by depression, which can cause unconsciousness and respiratory failure. These central effects result mainly from the activation of mAChRs, and are antagonized by atropine.
  • 40. 4- CVS • Cardiovascular effects are complex. •Whereas muscarinic action would produce bradycardia and hypotension. • Ganglionic stimulation would tend to increase heart rate and BP. •Action on medullary centres (stimulation followed by depression) further complicates the picture, so does ganglionic blockade with high doses. •Thus, the overall effects are often unpredictable and depend on the agent and its dose.
  • 41. 5-Neurotoxicity of organophosphates •Many organophosphates can cause a severe type of delayed peripheral nerve degeneration, leading to progressive weakness and sensory loss. •This is not a problem with clinically used anticholinesterases but occasionally results from poisoning with insecticides or nerve gases. • The mechanism of this reaction is only partly understood, but it seems to result from inhibition of a neuropathy target esterase distinct from cholinesterase.
  • 42. Physostigmine •It is an alkaloid obtained from dried ripe seeds of Physostigma venenosum. •A tertiary ammonium compound •Well absorbed from GIT and can cross BBB. •Equally active against both true and pseudo CE.
  • 43. Therapeutic uses of physostigmine 1. Pilocarpine- to treat glaucoma. 2. Atropine poisoining 3. Early stages of Alzhemier’s disease and improve memory.
  • 44. Therapeutic uses 1. Glaucoma- by contracting ciliary and circular muscle Drug useful is physostigmine in doses of 0.1- 1% aq solution or Pilocarpine 0.5- 4% Aq sol.
  • 45. 2. Mysthenia gravis – • by contraction of muscle • Drug used is neostigmine • As it cannot cross BBB and it directly produces cholinomimetic action • It has selective action on skeletal muscle
  • 46. 3. Atropine poisoining- physostigmine is commonly used as it can cross BBB 4. Curare poisoining- neostigmine is used 5. Misce. Use – Physostigmine is used in Alzhemiers disease by decreasing the metabolism of Ach •Methacholine & neostigmine are sometimes used in tachycardia
  • 47. • Attony of bladder and paralytic ileus– if the spasm of bladder is not proper than Methacholine carbachol is prescribed
  • 48. ANTICHOLINESTERASE POISONING •Anticholinesterases are easily available and extensively used as agricultural and household insecticides; accidental as well as suicidal and homicidal poisoning is common. •Local muscarinic manifestations at the site of exposure (skin, eye, g.i.t.) occur immediately and are followed by complex systemic effects due to muscarinic, nicotinic and central actions.
  • 49. They are— • Irritation of eye, lacrimation, salivation, sweating, copious tracheo-bronchial secretions, miosis, blurring of vision, bronchospasm, breathlessness, colic, involuntary defecation and urination. •Fall in BP, bradycardia or tachycardia, cardiac arrhythmias, vascular collapse.
  • 50. • Muscular fasciculations, weakness, respiratory paralysis (central as well as peripheral). • Irritability, disorientation, unsteadiness, tremor, ataxia, convulsions, coma and death. • Death is generally due to respiratory failure
  • 51. Treatment 1. Termination of further exposure to the poison— fresh air, wash the skin and mucous membranes with soap and water, gastric lavage according to need. 2. Maintain patent airway, positive pressure respiration if it is failing. 3. Supportive measures—maintain BP, hydration, control of convulsions with judicious use of diazepam. 4. Specific antidotes—
  • 52. (a) Atropine : •It is highly effective in counteracting the muscarinic symptoms, but higher doses are required to antagonize the central effects. •It does not reverse peripheral muscular paralysis which is a nicotinic action. •All cases of anti-ChE (carbamate or organophosphate) poisoning must be promptly given atropine 2 mg i.v. repeated every 10 min till dryness of mouth or other signs of atropinization appear (upto 200 mg has been administered in a day). Continued treatment with maintenance doses may be required for 1–2 weeks.
  • 53. (b) Cholinesterase reactivators •Oximes are used to restore neuromuscular transmission only in case of organophosphate anti-ChE poisoning. •The phosphorylated ChE reacts very slowly or not at all with water. •However, if more reactive OH groups in the form of oximes (generic formula R–CH = N–OH) are provided, reactivation occurs more than a million times faster.
  • 54. •Pralidoxime (2-PAM) has a positively charged quaternary nitrogen: attaches to the anionic site of the enzyme which remains unoccupied in the presence of organophosphate inhibitors. •Its oxime end reacts with the phosphorus atom attached to the esteratic site: the oxime-phosphonate so formed diffuses away leaving the reactivated ChE.
  • 55. • Pralidoxime is ineffective as an antidote to carbamate anti-ChEs (physostigmine, neostigmine, carbaryl, propoxur) in which case the anionic site of the enzyme is not free to provide attachment to it. •It is rather contraindicated in carbamate poisoning, because not only it does not reactivate carbamylated enzyme, it has weak anti-ChE activity of its own.
  • 56. Chronic organophosphate poisoning • Repeated exposure to certain fluorine containing and triaryl organophosphates results in polyneuritis and demyelination after a latent period of days to weeks. •Sensory disturbances occur first followed by muscle weakness, tenderness and depressed tendon reflexes—lower motor neurone paralysis.
  • 57. •In the second phase, spasticity and upper motor neurone paralysis gradually supervenes. •Recovery may take years. • The mechanism of this toxicity is not known, but it is not due to inhibition of ChE; there is no specific treatment.
  • 58. Adverse effects of parasympathomimetics • Excessive salivation • Asthma • Peptic ulcer • Coronary insuffiency • Hyperthyrodism • Apnoea • Nausea vomiting • Contraindication